Conflating polycythemia vera with essential thrombocytosis. [PDF]
Spivak JL.
europepmc +1 more source
Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b. [PDF]
Yoon SY +14 more
europepmc +1 more source
Toward new therapy end points in polycythemia vera: targeting clonal and inflammatory pathways. [PDF]
Barbui T, Scandura JM.
europepmc +1 more source
Different Colours of Polycythemia Vera: A Case Series. [PDF]
Viswanathan N, Adalarasan S, T S, S Y.
europepmc +1 more source
Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]
Boccia, Ralph V +7 more
core +1 more source
OCT angiography in polycythemia vera. [PDF]
Panigrahi PK.
europepmc +1 more source
Synchronous Primary Hyperparathyroidism and Polycythemia Vera: A Case Report and Literature Review. [PDF]
Montazeri M +3 more
europepmc +1 more source
The treatment of polycythaemia vera: an update in the JAK2 era [PDF]
G. Finazzi +34 more
core +1 more source
Complex Aortic Plaques and Polycythemia Vera Presenting as Blue Toe Syndrome Without Peripheral Arterial Disease. [PDF]
Chebrolu S +4 more
europepmc +1 more source
Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population-Based Study on Treatment Patterns, Vascular Complications and Survival. [PDF]
Larsson AE +5 more
europepmc +1 more source

